SCHEMBL15953003

SCHEMBL15953003

Cn1ccc(C(=O)NCCCc2ccccc2C(F)(F)F)c(O)c1=O

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 7/20 0.60
LIPC P11150 1/20 0.55
HDAC1 Q13547 2/20 0.41
HDAC8 Q9BY41 1/20 0.41
CNR1 P21554 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
PTGES O14684 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HSD17B13 Q7Z5P4 1/20 0.38
RAB9A P51151 1/20 0.38
SLC6A5 Q9Y345 1/20 0.38
HDAC3 O15379 1/20 0.38
AKR1B10 O60218 1/20 0.38
AKR1B1 P15121 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15952816 0.83 LIPG (0.48) LIPGLIPCKDM4EALDH1A1RAB9A
SCHEMBL15952791 0.82 LIPG (0.52) LIPGLIPCHDAC1HDAC8CNR1
SCHEMBL6858842 0.79 LIPG (0.67) LIPGLIPCL3MBTL1KDM4E
SCHEMBL8912311 0.79 LIPG (0.67) LIPGLIPCHDAC1L3MBTL1KDM4E
SCHEMBL6865227 0.78 LIPG (0.65) LIPGLIPCHDAC1KDM4EALDH1A1
SCHEMBL7043047 0.78 LIPG (0.65) LIPGLIPCHDAC1KDM4EALDH1A1
SCHEMBL15969592 0.77 L3MBTL1 (0.58) LIPGL3MBTL1KDM4EALDH1A1TDP1
SCHEMBL15953435 0.77 LIPG (0.65) LIPGLIPCL3MBTL1POLBALDH1A1
SCHEMBL15952357 0.76 LIPG (0.60) LIPGLIPCPOLBKDM4EALDH1A1
SCHEMBL8334416 0.76 LIPG (0.62) LIPGLIPCL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760834-B1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL MYERS SQUIBB CO (US) 2016-11-16 EP claimed
EP-2760834-B1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL MYERS SQUIBB CO (US) 2016-11-16 EP disclosed
US-8933235-B2 Pyridinedione carboxamide inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-01-13 US disclosed
US-8933235-B2 Pyridinedione carboxamide inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-01-13 US disclosed
US-8933235-B2 Pyridinedione carboxamide inhibitors of endothelial lipase BRISTOL-MYERS SQUIBB COMPANY (US) 2015-01-13 US disclosed
US-20140235673-A1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2014-08-21 US disclosed
US-20140235673-A1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2014-08-21 US disclosed
US-20140235673-A1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE BRISTOL-MYERS SQUIBB COMPANY 2014-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235673-A1 PYRIDINEDIONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE LIPG, PNLIP, LPL LIPG 1/4885LIPC 9/4885HDAC1 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.